We are live on
!
Find out more
MBE
Michael B. Elefante Portfolio holdings
AUM
$91.5M
Turnover
27.89%
1-Year Est. Return
13.24%
This Fund
S&P 500
This Quarter
Est. Return
+5.5%
1 Year Est. Return
+13.24%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$91.5M
AUM Growth
-$140M
(-61%)
Cap. Flow
-$147M
Cap. Flow
% of AUM
-161.07%
Top 10 Holdings %
Top 10 Hldgs %
32.18%
Holding
147
New
3
Increased
5
Reduced
92
Closed
38
Avg Time Held
1.2
years
Top 10 Avg Time Held
1.2
years
Top 20 Avg Time Held
1.2
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CDK
CDK Global, Inc.
CDK
|
+$327K |
| 2 |
COL
Rockwell Collins
COL
|
+$213K |
| 3 |
Cracker Barrel
CBRL
|
+$19.9K |
| 4 |
Stericycle Inc
SRCL
|
+$18.3K |
| 5 |
FRC
First Republic Bank
FRC
|
+$11.6K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CVS Health
CVS
|
+$6.51M |
| 2 |
Canadian National Railway
CNI
|
+$5.43M |
| 3 |
Novartis
NVS
|
+$5.24M |
| 4 |
Mastercard
MA
|
+$5.23M |
| 5 |
Johnson & Johnson
JNJ
|
+$5.15M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.99% |
| 2 | Healthcare | 21.06% |
| 3 | Industrials | 19.34% |
| 4 | Energy | 10.11% |
| 5 | Consumer Staples | 9.01% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
101
Cracker Barrel
CBRL
$1.4B
| $23K | 0.03% |
+165
| New | +$19.9K |
2014 Q4
0 quarters
|
|
102
DELISTED
Regal Entertainment Group
RGC
| $23K | 0.03% |
1,065
| – | – |
2014 Q1
3 quarters
|
|
103
Philip Morris
PM
$320B
| $20K | 0.02% |
245
-5
| -2% | -$429 |
2014 Q1
3 quarters
|
|
104
National Health Investors
NHI
$3.21B
| $19K | 0.02% |
275
-10
| -4% | -$650 |
2014 Q1
3 quarters
|
|
|
PBCT
105
DELISTED
People's United Financial Inc
PBCT
| $18K | 0.02% |
1,160
+100
| +9% | +$1.46K |
2014 Q1
3 quarters
|
|
106
Verizon
VZ
$185B
| $17K | 0.02% |
365
| – | – |
2014 Q3
1 quarter
|
|
107
Alnylam Pharmaceuticals
ALNY
$30B
| – | – |
-7,840
| Closed | -$612K | – |
|
108
Amgen
AMGN
$230B
| – | – |
-1,172
| Closed | -$165K | – |
|
109
American Express
AXP
$207B
| – | – |
-1,473
| Closed | -$129K | – |
|
110
Cognex
CGNX
$9.63B
| – | – |
-1,600
| Closed | -$32K | – |
|
111
Colgate-Palmolive
CL
$74B
| – | – |
-1,850
| Closed | -$121K | – |
|
112
Capital One
COF
$119B
| – | – |
-2,480
| Closed | -$202K | – |
|
113
Walt Disney
DIS
$188B
| – | – |
-1,950
| Closed | -$174K | – |
|
114
Corning
GLW
$121B
| – | – |
-13,380
| Closed | -$258K | – |
|
115
GSK
GSK
$95.9B
| – | – |
-18,100
| Closed | -$1.04M | – |
|
116
iShares Core S&P 500 ETF
IVV
$887B
| – | – |
-1,398
| Closed | -$277K | – |
|
117
Kimberly-Clark
KMB
$33.1B
| – | – |
-1,498
| Closed | -$154K | – |
|
118
Coca-Cola
KO
$395B
| – | – |
-3,445
| Closed | -$147K | – |
|
119
Labcorp
LH
$25.7B
| – | – |
-20,190
| Closed | -$1.76M | – |
|
120
McDonald's
MCD
$169B
| – | – |
-130
| Closed | -$12K | – |
|
121
MarketAxess Holdings
MKTX
$5.79B
| – | – |
-850
| Closed | -$53K | – |
|
122
J.M. Smucker
SJM
$13B
| – | – |
-3,360
| Closed | -$333K | – |
|
123
State Street SPDR S&P 500 ETF Trust
SPY
$813B
| – | – |
-8,100
| Closed | -$1.6M | – |
|
|
STKL
124
DELISTED
SunOpta
STKL
| – | – |
-42,000
| Closed | -$507K | – |
|
125
Stryker
SYK
$108B
| – | – |
-3,175
| Closed | -$256K | – |
|
Similar funds
AEPI
CC
TM
VNB
ECP
WIL
RCM
ZTNA
Michael B. Elefante's Q4 2014 Portfolio in Review
As of Q4 2014, Michael B. Elefante held 147 positions worth $91.5M, down 61% from $232M the previous quarter. Its ten largest holdings account for 32% of the portfolio.
Michael B. Elefante withdrew a net $147M in Q4 2014, closing 38 positions and reducing 92 holdings. Its most notable exit was Labcorp, an estimated $1.76M position sold in full.
By sector, the portfolio is most concentrated in Technology at 25% of assets, down from 26% a quarter earlier, followed by Healthcare and Industrials.
Against the trend, Michael B. Elefante opened a new position in CDK Global, Inc. worth $375K.
- Michael B. Elefante's largest Q4 2014 buy was CDK Global, Inc.: 9,235 shares worth $375K.
- Michael B. Elefante added most to Stericycle Inc in Q4 2014, an estimated $18.3K increase.
- Michael B. Elefante's biggest Q4 2014 reduction was CVS Health, cutting an estimated $6.51M.
- Michael B. Elefante fully exited Labcorp in Q4 2014, selling an estimated $1.76M.
- Michael B. Elefante's ten largest holdings make up 32% of its $91.5M portfolio in Q4 2014.
- Michael B. Elefante opened 3 new positions and closed 38 in Q4 2014.
- Michael B. Elefante's portfolio value fell 61% quarter-over-quarter to $91.5M.
Based on Michael B. Elefante's 13F filing for Q4 2014, filed 13 Feb 2015.